Saarbrucken, Germany

Ursapharm Arzneimittel Gmbh

Calculating rank
USPTO Granted Patents = 7

% Expired Patents = 28.6



Trademarks = 21

Forward Citations = 179

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Klaus Eschmann (3 out of 4 patents)

silverMedal Gunter Geimer (2 out of 2 patents)

bronzeMedal Ute Steinfeld (1 out of 10 patents)

4.  Frank Holzer (1 out of 9 patents)

5.  Rolf Müller (1 out of 13 patents)

6.  Josef Beuth (1 out of 1 patent)

7.  Rainer Maurer (1 out of 8 patents)

8.  Nora Luniak (1 out of 1 patent)

9.  Edyta Grabowska (1 out of 1 patent)

10.  Klaus Eckert (1 out of 1 patent)

11.  Dominik Holzer (1 out of 1 patent)

12.  Peter Gross (1 out of 1 patent)

13.  Holger Seelert (1 out of 1 patent)

14.  Peter Meiser (1 out of 1 patent)

15.  Rolf MÜLLER (1 out of 1 patent)


7 patents:

Company Overview
Ursapharm Arzneimittel GmbH is a pharmaceutical company specialized in the development, production, and distribution of ophthalmic and ENT products. With a focus on innovative solutions, Ursapharm aims to improve the quality of life for patients worldwide. The company's portfolio includes products for dry eyes, allergies, and various eye and ear conditions. Ursapharm is committed to excellence in research, manufacturing, and customer service.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

7 Patents

#4 in Saarbrucken

#4,867 in Germany

Saarbrucken, DE
Saarbrucken, Germany
Forward Citations = 179

14 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ursapharm Arzneimittel Gmbh. Retrieved from https://idiyas.com/company/ursapharm-arzneimittel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…